Clinical Trials on ASP7991 的药代动力学 in United States
总计9933个结果
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International Ltd完全的
-
Pharmaceutical Productions Inc.National Institute on Drug Abuse (NIDA)完全的
-
University of FloridaNational Center for Complementary and Integrative Health (NCCIH); Thorne HealthTech, Inc完全的
-
University of WashingtonOregon Health and Science University; National Institute of General Medical Sciences (NIGMS)未知
-
Celgene完全的
-
Daiichi Sankyo Co., Ltd.完全的
-
University of FloridaNational Center for Complementary and Integrative Health (NCCIH); Thorne HealthTech, Inc完全的
-
AstraZeneca完全的
-
Daiichi Sankyo Co., Ltd.完全的
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLC完全的
-
Texas Tech University Health Sciences CenterMerck Sharp & Dohme LLC终止
-
Duke UniversityNational Institute of General Medical Sciences (NIGMS)完全的
-
Amphastar Pharmaceuticals, Inc.完全的
-
Pfizer完全的药代动力学 | 细胞色素 P-450 CYP2D6 | CYP3A4 蛋白,人类美国
-
West Virginia University完全的
-
AstraZeneca完全的药代动力学 | 相对生物利用度 | AUC | 最高潮美国